PERSPECTIVE
Congenital heart disease
Transporting babies with known heart disease; who, what and where?
Correspondence to:
Correspondence to:
Dr Frances A Bu’lock
Congenital and Paediatric Cardiology Service, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK; frances.bu'lock@uhl-tr.nhs.uk
Perspective on the paper by Browning Carmo et al (see page 117)
| The first 150 words of the full text of this article appear below. |
Intravenous prostaglandin therapy is well established for maintaining or re-opening the arterial duct in newborns with duct dependent congenital heart disease. An important side effect of prostaglandin therapy is its tendency to cause apnoea. Hence elective intubation and ventilation is usually considered for infants who are transferred between hospitals soon after starting such an infusion.1 The article from Dr Browning Carmo et al2(see page xxx) provides an excellent justification for transporting such infants on intravenous prostaglandin without routine mechanical ventilation. However, although the authors do comment that this may also be suitable for infants with known duct dependent heart disease (ie diagnosed antenatally), they have not highlighted how many, if any, of their own study group fall within this category.
These patients are a challenging group and represent the worst end of the spectrum of congenital heart disease.3,4 Complex single ventricle lesions and severely
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Article
- Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation
- Kathryn A Browning Carmo, Peter Barr, Maureen West, Neil W Hopper, Jennifer P White, and Nadia Badawi
Arch. Dis. Child. Fetal Neonatal Ed. 2007 92: F117-F119.[Abstract] [Full Text] [PDF]
This article has been cited by other articles:
-
Ferrarese, P., Marra, A., Doglioni, N., Zanardo, V., Trevisanuto, D.
(2007). Routine mechanical ventilation for transferred neonates with duct-dependent congenital heart disease. Arch. Dis. Child. Fetal Neonatal Ed.
92: F422-F422
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in ADC Online
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Immunology (including allergy)
-
Drugs: cardiovascular system
-
Congenital heart disease
-
Pregnancy
-
Reproductive medicine
- Relevant Article
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
